PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology
31 janv. 2024 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application
23 janv. 2024 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA
09 janv. 2024 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 09, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH COVETRUS NORTH AMERICA, LLC
22 déc. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Dec. 22, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023
21 déc. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Dec. 21, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company"), an emerging biomedical device company focused on the commercialization of...
PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States
11 déc. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Dec. 11, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company"), an emerging biomedical device company focused on the commercialization of...
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California
21 nov. 2023 11h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Nov. 21, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
XOOX, the world's first pet networking service (PNS), creates buzz with its launch
21 nov. 2023 09h00 HE
|
XOOX LAB, Inc.
- Popular for its short-form content challenges, pet music, illness diagnosis kit app, etc. - Providing a newly conceptualized service with ID registration using pets’ eyes NEW YORK, Nov. 21,...
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
20 nov. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
14 nov. 2023 15h00 HE
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the...